Wednesday's Small-Cap Winners & Losers
Small-cap stocks fared slightly worse than the rest of the market today, pressured in part by Badger Meter's (BMI) disappointing first-quarter results.
The Milwaukee-based company, which makes scientific measurement and control products, said profits from continuing operations plummeted by more than half to 17 cents a share -- far short of the 31 cents sought by analysts, as per Thomson Financial. Shares were off $2.85, or 10.2%, to $25.
The Russell 2000, of which Badger is a component, recently slipped 0.3% to 826.77. Another broad tracker, the S&P SmallCap 600, was lately down 0.2% at 424.32.
Michigan's Dearborn Bancorp (DEAR) also widely missed first-quarter targets, reporting a 38.7% slide in "core" earnings to 19 cents a share. The bank was losing 10% to $15.60. Minnesota-based Lifecore Biomedical (LCBM), which missed by a penny, was giving up 8.7% to $17.66.Oscient Pharmaceuticals (OSCI) dropped as well, after the Waltham, Mass., drugmaker upped its ongoing convertible senior bond offering (first announced last month) by about two-thirds to $50 million. Shares lately shed 70 cents, or 9%, to $7.04. On the flip side, biotech Trimeris (TRMS) said its main product -- an HIV treatment called Fuzeon -- brought in around 16% more first-quarter revenue year over year to $64.3 million. Shares shot up $1.51, or 22.4%, to $8.25. Meanwhile, Canada's Peace Arch Entertainment (PAE), which produces the TV show "The Tudors," gained 14.6% to $2.04 after Showtime Networks renewed the series for another season. Elsewhere, Toronto's Vasogen (VSGND) spiked 9.6% to $4 on word Spain-based Grupo Ferrer Internacional will market Vasogen's Celacade product (a treatment for chronic heart failure) in the European Union and in certain Latin American countries. Ferrer will assume all associated costs while taking a cut of the sales. Lufkin Industries (LUFK), a Texas-based maker of oil-pumping equipment, reported $1.17 per-share earnings that sprinted past first-quarter estimates. Shares were leaping $5.78, or 9.8%, to $64.72.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV